Archive

Dis-Chem Insurance Branding Non-Compliant says CMS

Dis-Chem health insurance branding issues raise enforcement risk for Centriq’s MyHealth products and potential disruption for policyholders.

Read More

National Health Insurance Negotiations: SAMA Seeks NHI Talks

National Health Insurance Negotiations: SAMA meets Motsoaledi after Godongwana urges NHI litigants to seek a settlement.

Read More

NHI Truce Talks: Godongwana Pushes Settlement On NHI

NHI truce talks could end court battles and shift focus to workable reforms for universal health coverage.

Read More

Afrox Unpaid Invoices: Lawsuit Exposes Provincial Health Debt

Afrox Unpaid Invoices spark a R360m lawsuit, highlighting growing hospital debt, late payments, and risks to essential medical gas supplies.

Read More

NHI Court Challenges: Litigants Reject Settlement Call

The NHI Court Challenge crisis deepens as key litigants reject Enoch Godongwana’s settlement push, citing flawed consultation.

Read More

2026 Healthcare Watchlist: Nine Healthcare Stories to Track

Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.

Read More

Sizwe Hosmed Regulatory Allegations: Claims of Sabotage

Sizwe Hosmed’s regulatory allegations highlight claims of corruption, sabotage and racial bias in South Africa’s medical scheme industry.

Read More

Generic Semaglutide Set to Disrupt Global GLP‑1 Market

Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.

Read More

NHI Legal Challenges: Talks Stalled by Politics, Funding Gaps

Finance Minister Enoch Godongwana urged a truce in the NHI legal challenges, but political fault lines keep negotiations fragile.

Read More

NHI Legal Challenges: Minister Calls For Out‑Of‑Court Resolution

Finance Minister Godongwana urges the settlement of NHI legal challenges to fast‑track universal healthcare and ease delays from court cases.

Read More

US Healthcare Spending Rose Sharply to $5.3 Trillion in 2024

US healthcare spending in 2024 jumped 7.2% to $5.3 trillion, driven by rising insurance enrolment, service use, and administrative costs.

Read More

Aspen Pharmacare Business Sale Sparks Investor Optimism

Aspen Pharmacare business sale boosts investor confidence. A strategic pivot following a turbulent 2025 rebuilds financial flexibility.

Read More